Phase 3 Data for Oral Orexin Agonist in Narcolepsy Type 1 Published in NEJM
Key takeaways: Oveporexton improved mean sleep latency on the Maintenance of Wakefulness Test by 14.3 to 19.8 minutes…
What’s at stake as Beijing beats global peers with first approval of novel therapy
China’s drug regulator has for the first time approved a novel, globally trialled medicine ahead of authorities in…